Enliven Therapeutics, Inc. (ELVN)

NASDAQ: ELVN · Real-Time Price · USD

42.93

-0.23 (-0.53%)

At close: Apr 8, 2026, 4:00 PM EDT

42.55

-0.38 (-0.89%)

After-hours: Apr 8, 2026, 5:05 PM EDT

Enliven Therapeutics Employees

Enliven Therapeutics had 60 employees as of December 31, 2025. The number of employees decreased by 2 or -3.23% compared to the previous year.

Employees

Change

-2

Growth

-3.23%

Revenue / Employee

n/a

Profits / Employee

-$1,728,233

Market Cap

2.57B

Employees Chart

Date	Employees	Change (1Y)	Growth (1Y)
Dec 31, 2025	60	-2	-3.23%
Sep 30, 2025	65	8	14.04%
Jun 30, 2025	63	11	21.15%
Mar 31, 2025	65	15	30.00%
Dec 31, 2024	62	16	34.78%
Sep 30, 2024	57	13	29.55%
Jun 30, 2024	52	15	40.54%
Mar 31, 2024	50	21	72.41%
Dec 31, 2023	46	17	58.62%
Sep 30, 2023	44	20	83.33%
Jun 30, 2023	37	13	54.17%
Mar 31, 2023	29	-	-
Sep 30, 2022	24	-	-

Company Name	Employees
Zai Lab	1,784
Sarepta Therapeutics	835
Adaptive Biotechnologies	624
Ascentage Pharma Group International	605
Syndax Pharmaceuticals	298
Celldex Therapeutics	198
Relay Therapeutics	192
Day One Biopharmaceuticals	178